… human serum. We demonstrate the presence of specific glycans in pancreatic cancer serum
… N-linked glycopeptides from normal and pancreatic cancer serum were enriched using two …

… of altered glycosylation of several serum proteins prior to pancreatic cancer diagnosis, …
In summary, we have profiled numerous serum protein glycosylation sites and compared …

… glycosylation related to pancreatic cancer. A few studies on N-glycosylation profiles in
pancreatic cancer have … Here, we use an automated protocol for the analysis of the total serum N-…

… (11, 12) Therefore, in the present study, we investigated the serum N-glycome profiles of
patients with pancreatic cancer and nonmalignant controls to identify potential new biomarkers. …

… Increased fucosylation can be detected in serum from patients with pancreatic cancer (56), …
To fully exploit glycans clinically it will be vital to fully profile the pancreatic cancer glycome …

… Furthermore, the analytical method used in the present study measured the glycosylation
levels of serum proteins and no additional characterization of the individual glycans was …

… Analysis on 13 sample sets was performed in this study, … from pancreatic cancer serum
(Figure 3B) is also similar to that of N-glycosylation sites in proteins derived from human pancreas …

… Their glycosylation levels were found to be elevated in pancreatic cancer serum in this study
using a RP HPLC-fraction microarray method 28. Both of these two glycoproteins produced …

… one or two, but not all, N-glycosylation sites in a specific glycoprotein. In conclusion, the
analysis shows that pancreatic cancer, and acute pancreatitis are associated with changes in …

… tumor markers are glycoproteins with altered glycan profiles [6,7]. Alterations in glycosylation
are frequently observed in serum … used as serum biomarkers for diagnosis of cancers [8,9]. …